Drugs / TBC-M4
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00902824 Comparator | Nov 2008 → Apr 2010 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TBC-M4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00902824 ↗ |
| Modality | Vaccine | “TBC-M4 (MVA Based HIV Vaccine)” NCT00902824 ↗ |
| Route | Intramuscular | “TBC-M4 (IM)” NCT00902824 ↗ |